文献速递急性肾损伤肾小球疾病遗传性与小管间质肾病

甲基苯丙胺使用相关的肾活检病理谱

Spectrum of Kidney Biopsy Findings Associated With Methamphetamine Use.
PubMed 文献 · Kidney Int Rep · 2024-05-01

本研究回顾性分析112例有甲基苯丙胺(METH)滥用史的患者肾活检资料,其中62例仅用METH,60例合并其他药物滥用。仅用METH组平均年龄41岁,76%为男性,97%活检时存在肾功能异常,最常见病理诊断为急性肾小管坏死(66%),其次为局灶节段性肾小球硬化(53%)。结论提示METH使用者多表现为急性肾损伤,且蛋白尿常见,肾脏病理谱广泛。

要点

  • METH使用者活检时97%存在肾功能异常,66%为急性肾小管坏死。
  • 仅用METH组53%有局灶节段性肾小球硬化,其中76%为非特殊型。
  • 合并乙醇滥用与肌红蛋白管型性急性肾小管坏死相关(P=0.002)。

核心结论

  • 多数METH使用者表现为急性肾损伤,常伴蛋白尿,肾脏病理谱广泛。

研究设计与样本

  • 回顾性研究,纳入112例有METH滥用史的患者,其中62例仅用METH,60例合并其他药物滥用。

主要发现

  • 仅用METH组平均年龄41岁(IQR 33-49),76%为男性,97%活检时存在肾功能异常。
  • 仅用METH组65%有蛋白尿,其中53%为肾病范围,10%有肾病综合征。
  • 最常见活检诊断为急性肾小管坏死(66%),其中19%有肌红蛋白管型;局灶节段性肾小球硬化占53%(非特殊型76%,塌陷型18%)。
  • 其他病变包括小管间质性肾炎(37%)、血栓性微血管病(24%)、糖尿病肾小球硬化(31%)。
  • 肾小球肾炎占三分之一,最常见为感染相关肾小球肾炎(15%)和IgA肾病(11%);肾小球肾炎患者中64%有潜在感染。

关键数值与推荐

  • 合并乙醇滥用与肌红蛋白管型性急性肾小管坏死关联增加(P=0.002)。
  • 仅用METH患者相比多药滥用者更易有糖尿病肾小球硬化(P=0.01)。
  • 超过半数患者有至少中度至重度小管间质瘢痕和显著高血压性血管病。

临床怎么用

  • 对METH使用者应警惕急性肾损伤和蛋白尿,肾活检可揭示多种病理类型。
  • 合并乙醇滥用者需注意肌红蛋白管型性急性肾小管坏死风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Methamphetamine (METH) is one of the most used drugs of abuse worldwide. However, there are few reports and series examining the toxic kidney effects of METH, and associated histopathological changes are not well-described. METHODS: We retrospectively identified 112 patients with a history significant for METH abuse, of whom 62 were using METH-only and 60 were using METH plus other drugs of abuse. RESULTS: In the METH-only cohort, the mean age was 41 years (interquartile range [IQR]: 33-49) and most (76%) were male. Almost all cases (97%) showed evidence of kidney dysfunction at the time of biopsy. Of the cases, 65% had proteinuria, of which 53% were nephrotic range and 10% had nephrotic syndrome. The most common biopsy diagnosis was acute tubular necrosis (ATN) (66%), of which 19% had myoglobin casts; followed by focal segmental glomerulosclerosis (FSGS) in 53% (not otherwise specified [NOS] in 76% and collapsing FSGS [cFSGS] in 18%). Biopsy findings also include tubulointerstitial nephritis (TIN) (37%), thrombotic microangiopathy (TMA) (24%), and diabetic glomerulosclerosis (DG) (31%). Glomerulonephritis (GN) was identified in one-third of cases, the most common of which were infection-related GN (IRGN) (15%) and IgA nephropathy (IgAN) (11%). Of those with GN, 64% had underlying infection. Of interest, there was increased association for myoglobinuric ATN in those with concurrent ethanol-abuse (P = 0.002). Moreover, the METH-only patients were more likely to have DG compared to those with multiple substance-use (P = 0.01). More than half of the patients demonstrated at least moderate to severe tubulointerstitial scarring and marked hypertensive vascular disease. CONCLUSION: Most patients with METH-use present with acute kidney injury (AKI) and often have proteinuria associated with a wide spectrum of renal pathology.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Grace Choung HY, Nast CC, Haas M, et al. Spectrum of Kidney Biopsy Findings Associated With Methamphetamine Use. Kidney Int Rep. 2024. PMID: 39081731. doi:10.1016/j.ekir.2024.04.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。